Antiemetic therapy of fosaprepitant, palonosetron, and dexamethasone combined with cisplatin-based chemotherapy for head and neck carcinomas.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Dexamethasone (Primary) ; Fosaprepitant (Primary) ; Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 09 Dec 2015 New trial record